Regeneron Pharmaceuticals, Inc. faces declining Eylea sales due to competition from Roche's Vabysmo and biosimilars like Amgen's Pavblu, but Dupixent's strong growth and new indications provide a robust near-term revenue driver. Libtayo and the oncology pipeline offer potential, but face tough competition and are unlikely to become blockbuster catalysts in the short term. The company's move into obesity drugs is a favorable development, with considerable potential from its experimental drug Trevogrumab, which shows promise in early trial data.

The drone market in the United States is projected to reach about $5.5 billion in 2029, expanding at a CAGR of 10.3% from 2024 through that period. Drones have varied applications in civil, commercial, and defense settings and have become indispensable to everything from weather monitoring to surveillance to military endeavors.

The most important quality of a dividend investment is longevity. Nobody cares about a high yield if the company won't be around in a decade or two.

FE's focus on infrastructure upgrades should improve its service reliability and overall performance.

Intuitive Surgical raises 2025 procedure outlook after strong Q1 growth, but rising costs and tariff pressure weigh on margins.

SLB flags flat Q2 revenues and EBITDA as drilling slows in Saudi Arabia and Latin America, denting margins.

E and Novamont have been fined over 32 million euros by Italy's antitrust watchdog for abusing market dominance in bioplastics.

Winnebago Industries (WGO) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $1.13 per share a year ago.

There have been plenty of rumors that Tesla Inc. (NASDAQ: TSLA) has so many unsold new cars in its inventory that it has run out of space to park them adjacent to its factories.

Walmart Inc. (NYSE: WMT) wants to speed up the pace at which it can deliver to customers who order online.

Gilead Sciences has entered into an option and license deal with Kymera Therapeutics to support the development and sales of a class of cancer drugs, the companies said on Wednesday.

Enhancements enable users to easily use AI-generated insights and recommendations to effectively manage equipment operations and maintenance KENNESAW, Ga. , June 25, 2025 /PRNewswire/ -- Carrier's latest enhancements to its Abound Insights Assistant app further empowers building managers and facilities teams to manage equipment operations proactively, while helping them streamline maintenance activities.

Retirement income portfolios must prioritize risk mitigation and avoid speculation to safeguard future cash flows and financial independence. So, the notion of making tactical investment plays seems to be inconsistent with such a philosophy. Yet, under certain circumstances and with all of the retirement-proof investment criteria being fulfilled, it could be a justified decision.

OKLAHOMA CITY--(BUSINESS WIRE)--Paycom Software, Inc. (NYSE: PAYC) (“Paycom”), a leading provider of comprehensive, cloud-based human capital management software, revealed findings from a study conducted by Forrester Consulting on the potential benefits gained through Paycom's full-solution automation and single-database software.* According to the Forrester Total Economic Impact™ (TEI) study, a composite organization representative of interviewed Paycom clients experienced a three-year 362% re.

NEW YORK, NY / ACCESS Newswire / June 25, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announces the strategic deconsolidation of its wholly owned subsidiary, Metuchen Pharmaceuticals LLC ("Metuchen"), including its wholly owned subsidiaries, Timm Medical Technologies, Inc. and Pos-T-Vac, LLC, from its consolidated balance sheet, effective beginning in its Quarterly Report on Form 10-Q for the quarter ending June 30, 2025. This move is expected to significantly improve Petros' financial position, increasing stockholders' equity and materially reducing consolidated …

HAMILTON, Bermuda--(BUSINESS WIRE)--Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing best-in-class property, casualty, and specialty reinsurance and insurance solutions, announced that Pamela Sinclair will join Everest as EVP, Chief Human Resources Officer, effective July 14. Ms. Sinclair will report to Jim Williamson, Everest President and CEO, and will serve on the Company's Executive Leadership Team. Ms. Sinclair succeeds Gail Van Beveren, Everest's Chief Human Resource.

New collaboration provides real-world experience, $10,000 tuition reimbursement, and career advancement support for HVACR students. PHOENIX , June 25, 2025 /PRNewswire/ -- Universal Technical Institute (UTI), the transportation, skilled trades, electrical, and energy education division of Universal Technical Institute, Inc., today announced that FirstCall Mechanical , a leading provider of HVACR services to commercial and industrial sectors, has joined its Early Employment Program (EEP).

ENGLEWOOD, Colo. , June 25, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has been awarded UK patent 2617515 for a multiparameter, noninvasive sepsis monitor.

I'm upgrading FCX to a buy, as improved valuation and a sufficient margin of safety offset recent sideways performance and mixed technicals. Strong Q1 results, lower net cash costs, and steady revenue growth projections support the investment case, despite global economic uncertainties. Key risks include geopolitical exposure, a strong U.S. dollar, operational challenges, and China's unpredictable economic outlook.

Welcome to the Green Stock News brief for Wednesday June 25th. Here are today's top headlines: IonQ (NYSE: IONQ) has achieved the first known quantum computer simulation of double-beta decay, a rare nuclear process that could help explain the universe's imbalance between matter and antimatter.